Our work also reveals that BRAF and components of the MAPK pathway are potential novel candidate genes for congenital pituitary disease, such as SOD, or isolated or CPHDs, and thus mutations in components of the MAPK pathway could be mutated in CPHD. The gene discussed is SOD1; the disease is pituitary gland disorder.